Publications by CIDSA

Publications

Commercial Savings Generated by Market-Wide Inflation Penalties on Drug Price Increases

September 27, 2022

Commercial Savings Generated by Spillover from Medicare Inflation Penalties under the Inflation Reduction Act of 2022

September 8, 2022

Monthly Insulin Caps Estimated to Save Seniors in Part D $965 a Year in Out-of-Pocket Costs

August 16, 2022

New study quantifies impact of monthly cost sharing caps on Part D beneficiaries

Estimated Changes in Spending for Insulin Under the Inflation Reduction Act of 2022

August 15, 2022

Estimated Payments Under the Inflation Penalty in the Build Back Better Act

Federal Revenue Generated by Extending Drug Price Inflation Caps to the Commercial Market

November 3, 2021

Impact Estimate of a $2,000 Out-of-Pocket Cap in Medicare Part D

October 27, 2021

Estimated Medicare Savings from Domestic Reference Pricing

September 23, 2021

Drug Pricing Policy Savers Playbook

August 19, 2021

Will Reducing Drug Prices Slow Innovation?

August 12, 2021

Extending PBM Rebates to Medicare Beneficiaries Without Increasing Medicare Spending

Commercial Savings Generated by Medicare Negotiation Under H.R. 3

High Drug Prices and Patient Costs: Millions of Lives and Billions of Dollars Lost

November 18, 2020

Cost related non-adherence could cause 1.1 million seniors to die prematurely by 2030

How Much Can Pharma Lose?

A Comparison of Returns Between Pharmaceutical and Other Industries

© 2020 West Health

We are an independent, nonpartisan expert group funded by West Health and focused on bringing a non-pharma perspective to drug spending policy dialogue.

West Health is dedicated to lowering healthcare costs to enable seniors to successfully age in place with access to high-quality, affordable health and support services that preserve and protect their dignity, quality of life and independence.